dc.contributor.author | Martínez Campa, Carlos Manuel | es_ES |
dc.contributor.author | Alonso González, Carolina | es_ES |
dc.contributor.other | Universidad de Cantabria | es_ES |
dc.date.accessioned | 2022-12-02T16:41:17Z | |
dc.date.available | 2022-12-02T16:41:17Z | |
dc.date.issued | 2020 | es_ES |
dc.identifier.issn | 1661-6596 | es_ES |
dc.identifier.issn | 1422-0067 | es_ES |
dc.identifier.other | SAF2016-77103-P | es_ES |
dc.identifier.uri | https://hdl.handle.net/10902/26825 | |
dc.description.abstract | The Special Issue entitled "New Strategies in Cancer Pharmacotherapy: Development of Hormonal Antineoplastic Drugs, Cytotoxic Drugs and Targeted Therapies" was conceived with the idea of compiling information on the latest advances in the treatment of both hormone-dependent and hormone-independent cancers [...]. | es_ES |
dc.description.sponsorship | The present study was funded by grants from the Spanish Economy and Competitiveness Ministry (SAF2016-77103-P) and from Instituto de Investigación Sanitaria Valdecilla (NVAL 16/01). | es_ES |
dc.format.extent | 4 p. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | MDPI | es_ES |
dc.rights | Attribution 4.0 International | * |
dc.rights | © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution(CC BY) license. | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.source | Int J Mol Sci
. 2020 Jun 8;21(11):4081 | es_ES |
dc.title | Editorial for the special issue “new strategies in cancer pharmacotherapy: Development of hormonal antineoplastic drugs, cytotoxic drugs and targeted therapies” | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherVersion | https://www.doi.org/10.3390/ijms21114081 | es_ES |
dc.rights.accessRights | openAccess | es_ES |
dc.identifier.DOI | 10.3390/ijms21114081 | es_ES |
dc.type.version | publishedVersion | es_ES |